O85207 (R)-3-hydroxydecanoyl-ACP:CoA transacylase MolNFT, Molecular NFT on GenesisL1

(R)-3-hydroxydecanoyl-ACP:CoA transacylase

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeiflorr4vad2oni5dvf3d7kkh3e3hhyjxkupoan7cdo4em4obtqnta/metadata.json

IPFS of structure file:

bafybeibr56vwpvhhdk2w7prnqr5tkvrp3syjcmxdjculwsfdjbonzbv6t4/AF-O85207-F1-model_v2.pdb

First NFT owner address (eip-55):

0x0cf0de7C33C7d40E89b93615e67E93838e943754

First NFT owner address (bech32):

genesis1pncdulpncl2qazdexc27vl5nsw8fgd65yak4mx

Current NFT ID #297500 owner (web3):

0xc672026d403F8F9B1631F769bF343e5571d0Bdf3

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
297500
Accession (UniProt):
O85207
Name::
(R)-3-hydroxydecanoyl-ACP:CoA transacylase
Experimental Method:
Predicted structure
Sequence source:
Pseudomonas putida (strain ATCC 47054 / DSM 6125 / CFBP 8728 / NCIMB 11950 / KT2440)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT O85207 research and analysis (ICN3D with VR)

FASTA sequences

>sp|O85207|PHAG_PSEPK (R)-3-hydroxydecanoyl-ACP:CoA transacylase OS=Pseudomonas putida (strain ATCC 47054 / DSM 6125 / CFBP 8728 / NCIMB 11950 / KT2440) OX=160488 GN=phaG PE=4 SV=1 MRPEIAVLDIQGQYRVYTEFYRADAAENTIILINGSLATTASFAQTVRNLHPQFNVVLFDQPYSGKSKPHNRQERLISKETEAHILLELIEHFQADHVMSFSWGGASTLLALAHQPRYVKKAVVSSFSPVINEPMRDYLDRGCQYLAACDRYQVGNLVNDTIGKHLPSLFKRFNYRHVSSLDSHEYAQMHFHINQVLEHDLERALQGARNINIPVLFINGERDEYTTVEDARQFSKHVGRSQFSVIRDAGHFLDMENKTACENTRNVMLGFLKPTVREPRQRYQPVQQGQHAFAI

O85207 AF NFT

MOLNFT AF v1

NFT data

MOLNFT O85207 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience